secwatch.observer — SEC 8-K summary
======================================

Issuer:     LanzaTech Global, Inc. (LNZA)
CIK:        0001843724
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001628280-24-041648
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LanzaTech expands into nutritional protein production from CO2; pre-commercial plant by 2026, commercial by 2028
--------------------------------------------------------------------------------

- LanzaTech announces LanzaTech Nutritional Protein (LNP) as primary product using new microbe in gas fermentation.
- Engineering phase for 0.5–1.5 tons/day pre-commercial facility expected operational in 2026.
- First commercial facility (>30,000 MT/yr) targeted for 2028, targeting $1 trillion alternative protein market.
- LNP has complete amino acid profile; GRAS certification for human nutrition underway.
- Partnerships include U.S. Navy Research Lab for military platforms and Mattson for food prototyping.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1843724/000162828024041648/0001628280-24-041648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1843724/000162828024041648/amci-20241001.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-041648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer